Price target upside
Gilead Sciences Price Target: +1.6% vs Current Price
Direct answer
Gilead Sciences's analyst target implies +1.6%.
The average target is $159.85 compared with a recorded current price of $157.37.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked October 16, 2026.
Get free Gilead Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $157.37
- Average price target
- $159.85
- High price target
- $180.00
- Low price target
- $126.00
- Low target gap
- -19.9%
- Target upside
- +1.6%
- High target gap
- +14.4%
- Target range width
- 34.3%
- Consensus rating
- Buy
- Analysts
- 26
- Evidence date
- October 16, 2026
- Valid through
- October 23, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Gilead Sciences's average target imply?
Gilead Sciences's average target is $159.85 versus a recorded price of $157.37. The difference is +1.6%.
How far are Gilead Sciences's low and high targets from the recorded price?
The low target implies -19.9%, while the high target implies +14.4%.
How many analysts are included in Gilead Sciences's consensus?
The verified consensus includes 26 analysts.
How is Gilead Sciences's target upside or downside calculated?
The average target of $159.85 is divided by the recorded price of $157.37, then one is subtracted to produce +1.6%. This does not guarantee a future return.
When was Gilead Sciences's analyst forecast verified?
The data was verified on 2026-10-16. The dataset is valid through 2026-10-23.